Effects of herpes simplex virus amplicon transduction on murine dendritic cells

Human Gene Therapy

Volumn 20, Issue 5, 2009, Pages 442-452

  Chiu, Yahui Grace ^a   Bowers, William J ^a   Lim, Seung T ^a,b   Ryan, Deborah A ^a   Federoff, Howard J ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOPROTEIN P 15095; HERPESVIRUS VECTOR; HVEA PROTEIN; HVEC PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NECTIN 1; UNCLASSIFIED DRUG;

AMPLICON; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL ADHESION MOLECULES; DENDRITIC CELLS; FEMALE; GENE THERAPY; HERPESVIRUS 1, HUMAN; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; TRANSDUCTION, GENETIC;

HUMAN HERPESVIRUS 1; MURINAE; SIMPLEXVIRUS;

EID: 66149120947     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.160     Document Type: Article

References (73)

1. Alnaeeli, M., Park, J., Mahamed, D., Penninger, J.M., and Teng, Y.T. (2007). Dendritic cells at the osteo-immune interface: Implications for inflammation-induced bone loss. J. Bone Miner. Res. 22, 775-780.
2. Bender, F.C., Whitbeck, J.C., Lou, H., Cohen, G.H., and Eisenberg, R.J. (2005). Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry. J. Virol. 79, 11588-11597.
3. Bennett, J.J., Delman, K.A., Burt, B.M., Mariotti, A., Malhotra, S., Zager, J., Petrowsky, H., Mastorides, S., Federoff, H., and Fong, Y. (2002). Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer. Cancer Gene Ther. 9, 935-945.
4. Bowers, W.J., Howard, D.F., and Federoff, H.J. (2000). Discordance between expression and genome transfer titering of HSV amplicon vectors: Recommendation for standardized enumeration. Mol. Ther. 1, 294-299.
5. Bowers, W.J., Howard, D.F., Brooks, A.I., Halterman, M.W., and Federoff, H.J. (2001). Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers. Gene Ther. 8, 111-120.
6. Bowers, W.J., Chen, X., Guo, H., Frisina, D.R., Federoff, H.J., and Frisina, R.D. (2002). Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol. Ther. 6, 12-18.
7. Bowers, W.J., Olschowka, J.A., and Federoff, H.J. (2003). Immune responses to replication-defective HSV-1 type vectors within the CNS: Implications for gene therapy. Gene Ther. 10, 941-945.
8. Bowers, W.J., Mastrangelo, M.A., Stanley, H.A., Casey, A.E., Milo, L.J., Jr., and Federoff, H.J. (2005). HSV ampliconmediated Aβ vaccination in Tg2576 mice: Differential antigenspecific immune responses. Neurobiol. Aging 26, 393-407.
9. Buchsel, P.C., and DeMeyer, E.S. (2006). Dendritic cells: Emerging roles in tumor immunotherapy. Clin. J.Oncol. Nurs. 10, 629-640.
10. Carew, J.F., Kooby, D.A., Halterman, M.W., Kim, S.H., Federoff, H.J., and Fong, Y. (2001). A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes. Mol. Ther. 4, 250-256.
11. Caux, C., Ait-Yahia, S., Chemin, K., De Bouteiller, O., Dieu-Nosjean, M.C., Homey, B., Massacrier, C., Vanbervliet, B., Zlotnik, A., and Vicari, A. (2000). Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22, 345-369.
12. Celluzzi, C.M., and Falo, L.D., Jr. (1998). Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J. Immunol. 160, 3081-3085.
13. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T., and Falo, L.D., Jr. (1996). Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-287.
14. Condon, C., Watkins, S.C., Celluzzi, C.M., Thompson, K., and Falo, L.D., Jr. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2, 1122-1128.
15. Copeland, R., Balasubramaniam, A., Tiwari, V., Zhang, F., Bridges, A., Linhardt, R.J., Shukla, D., and Liu, J. (2008). Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 47, 5774-5783.
16. de Jong, E.C., Smits, H.H., and Kapsenberg, M.L. (2005). Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26, 289-307.
17. Delman, K.A., Zager, J.S., Bennett, J.J., Malhotra, S., Ebright, M.I., McAuliffe, P.F., Halterman, M.W., Federoff, H.J., and Fong, Y. (2002). Efficacy of multiagent herpes simplex virus amplicon-mediated immunotherapy as adjuvant treatment for experimental hepatic cancer. Ann. Surg. 236, 337-342; discussion 342-333.
18. Detrait, E.R., Bowers, W.J., Halterman, M.W., Giuliano, R.E., Bennice, L., Federoff, H.J., and Richfield, E.K. (2002). Reporter gene transfer induces apoptosis in primary cortical neurons. Mol. Ther. 5, 723-730.
19. + cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: A phase I trial [clinical protocol]. Hum. Gene Ther. 14, 1347-1360.
20. Dubsky, P., Ueno, H., Piqueras, B., Connolly, J., Banchereau, J., and Palucka, A.K. (2005). Human dendritic cell subsets for vaccination. J. Clin. Immunol. 25, 551-572.
21. Fajardo-Moser, M., Berzel, S., and Moll, H. (2008). Mechanisms of dendritic cell-based vaccination against infection. Int. J. Med. Microbiol. 298, 11-20.
22. Figdor, C.G., De Vries, I.J., Lesterhuis, W.J., and Melief, C.J. (2004). Dendritic cell immunotherapy: Mapping the way. Nat. Med. 10, 475-480.
23. Galli, S.J., Tsai, M., and Piliponsky, A.M. (2008). The development of allergic inflammation. Nature 454, 445-454.
24. Geschwind, M.D., Hartnick, C.J., Liu, W., Amat, J., Van De Water, T.R., and Federoff, H.J. (1996). Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: Model for treatment of neuron loss following cochlear degeneration. Hum. Gene Ther. 7, 173-182.
25. Gordon, S., and Taylor, P.R. (2005). Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
26. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S. (2002). Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667.
27. Hartgers, F.C., Figdor, C.G., and Adema, G.J. (2000). Towards a molecular understanding of dendritic cell immunobiology. Immunol. Today 21, 542-545.
28. He, Y., Zhang, J., Mi, Z., Robbins, P., and Falo, L.D., Jr. (2005). Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J. Immunol. 174, 3808-3817.
29. Inaba, K., Metlay, J.P., Crowley, M.T., and Steinman, R.M. (1990). Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172, 631-640.
30. Iwashita, Y., Goto, S., Tominaga, M., Sasaki, A., Ohmori, N., Goto, T., Sato, S., Ohta, M., and Kitano, S. (2005). Dendritic cell immunotherapy with poly(D,L-2,4-diaminobutyric acid)-mediated intratumoral delivery of the interleukin-12 gene suppresses tumor growth significantly. Cancer Sci. 96, 303-307.
31. Jensen, P.E. (2005). Dendritic cells: Caspases keep them young. Nat. Immunol. 6, 968-969.
32. Johnson, D.C., Ghosh-Choudhury, G., Smiley, J.R., Fallis, L., and Graham, F.L. (1988). Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164, 1-14.
33. Koya, R.C., Kasahara, N., Favaro, P.M., Lau, R., Ta, H.Q., Weber, J.S., and Stripecke, R. (2003). Potent maturation of monocyte- derived dendritic cells after CD40L lentiviral gene delivery. J. Immunother. 26, 451-460.
34. + monocytes generates dendritic cells in vitro. Hum. Gene Ther. 15, 733-748.
35. Krummenacher, C., Baribaud, I., Ponce De Leon, M., Whitbeck, J.C., Lou, H., Cohen, G.H., and Eisenberg, R.J. (2000). Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies. J. Virol. 74, 10863-10872.
36. Kwon, H., Bai, Q., Baek, H.J., Felmet, K., Burton, E.A., Goins, W.F., Cohen, J.B., and Glorioso, J.C. (2006). Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D. J. Virol. 80, 138-148.
37. Li, P., Wang, N., Zhou, D., Yee, C.S., Chang, C.H., Brutkiewicz, R.R., and Blum, J.S. (2005). Disruption of MHC class II-restricted antigen presentation by vaccinia virus. J. Immunol. 175, 6481-6488.
38. Lim, S.T., Lim, K.C., Giuliano, R.E., and Federoff, H.J. (2008). Temporal and spatial localization of nectin-1 and l-afadin during synaptogenesis in hippocampal neurons. J. Comp. Neurol. 507, 1228-1244.
39. Liu, Y., Chiriva-Internati, M., Grizzi, F., Salati, E., Roman, J.J., Lim, S., and Hermonat, P.L. (2001). Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector. Cancer Gene Ther. 8, 948-957.
40. Lutz, M.B., Kukutsch, N., Ogilvie, A.L., Rossner, S., Koch, F., Romani, N., and Schuler, G. (1999). An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.J.Immunol. Methods 223, 77-92.
41. Mahnke, K., and Enk, A.H. (2005). Dendritic cells: Key cells for the induction of regulatory T cells? Curr. Top. Microbiol. Immunol. 293, 133-150.
42. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Celluzzi, C., Falo, L.D., Melief, C.J., Ildstad, S.T., Kast, W.M., Deleo, A.B., and Lotze, M.T. (1995). Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1, 1297-1302.
43. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Garcia-Prats, M.D., Deleo, A.B., and Lotze, M.T. (1997). Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines. Stem Cells 15, 94-103.
44. Moll, H. (2004). Antigen delivery by dendritic cells. Int. J. Med. Microbiol. 294, 337-344.
45. H2 development. Nat. Immunol. 1, 199-205.
46. Neumann, J., Eis-Hubinger, A.M., and Koch, N. (2003). Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol. 171, 3075-3083.
47. Nouri-Shirazi, M., Banchereau, J., Fay, J., and Palucka, K. (2000). Dendritic cell based tumor vaccines. Immunol. Lett. 74, 5-10.
48. Oehmig, A., Fraefel, C., and Breakefield, X.O. (2004a). Update on herpesvirus amplicon vectors. Mol. Ther. 10, 630-643.
49. Oehmig, A., Fraefel, C., Breakefield, X.O., and Ackermann, M. (2004b). Herpes simplex virus type 1 amplicons and their hybrid virus partners, EBV, AAV, and retrovirus. Curr. Gene Ther. 4, 385-408.
50. Paczesny, S., Ueno, H., Fay, J., Banchereau, J., and Palucka, A.K. (2003). Dendritic cells as vectors for immunotherapy of cancer. Semin. Cancer Biol. 13, 439-447.
51. Palucka, A.K., Laupeze, B., Aspord, C., Saito, H., Jego, G., Fay, J., Paczesny, S., Pascual, V., and Banchereau, J. (2005). Immunotherapy via dendritic cells. Adv. Exp. Med. Biol. 560, 105-114.
52. Reske, A., Pollara, G., Krummenacher, C., Katz, D.R., and Chain, B.M. (2008). Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J. Immunol. 180, 7525-7536.
53. Salio, M., Cella, M., Suter, M., and Lanzavecchia, A. (1999). Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29, 3245-3253.
54. Santambrogio, L., Potolicchio, I., Fessler, S.P., Wong, S.H., Raposo, G., and Strominger, J.L. (2005). Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells. Nat. Immunol. 6, 1020-1028.
55. Santos, K., Sanfilippo, C.M., Narrow, W.C., Casey, A.E., Rodriguez-Colon, S.M., McDermott, M.P., Federoff, H.J., Bowers, W.J., and Dewhurst, S. (2007). Infectivity of herpes simplex virus type-1 (HSV-1) amplicon vectors in dendritic cells is determined by the helper virus strain used for packaging. J. Virol. Methods 145, 37-46.
56. Shukla, D., Liu, J., Blaiklock, P., Shworak, N.W., Bai, X., Esko, J.D., Cohen, G.H., Eisenberg, R.J., Rosenberg, R.D., and Spear, P.G. (1999). A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13-22.
57. Sortwell, C.E., Bowers, W.J., Counts, S.E., Pitzer, M.R., Fleming, M.F., McGuire, S.O., Maguire-Zeiss, K.A., Federoff, H.J., and Collier, T.J. (2007). Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival. Brain Res. 1134, 33-44.
58. Spear, P.G., Manoj, S., Yoon, M., Jogger, C.R., Zago, A., and Myscofski, D. (2006). Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry. Virology 344, 17-24.
59. Takayama, T., Tahara, H., and Thomson, A.W. (1999). Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells. Transplantation 68, 1903-1909.
60. Tamir, A., Basagila, E., Kagahzian, A., Jiao, L., Jensen, S., Nicholls, J., Tate, P., Stamp, G., Farzaneh, F., Harrison, P., Stauss, H., George, A.J., Habib, N., Lechler, R.I., and Lombardi, G. (2007). Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunol. Immunother. 56, 2003-2016.
61. Tan, H., Zeng, L.J., and Ye, X. (2005). Ex vivo induction of antileukemia cytotoxic T cell effect by dendritic cells from human umbilical cord blood cell origin. Zhongguo Shi Yan Xue Ye Xue Za Zhi 13, 472-478.
62. Taylor, P.R., and Gordon, S. (2003). Monocyte heterogeneity and innate immunity. Immunity 19, 2-4.
63. Terry-Allison, T., Montgomery, R.I., Whitbeck, J.C., Xu, R., Cohen, G.H., Eisenberg, R.J., and Spear, P.G. (1998). HveA (herpesvirus entry mediator A), a coreceptor for herpes sim- plex virus entry, also participates in virus-induced cell fusion. J. Virol. 72, 5802-5810.
64. Timares, L., Douglas, J.T., Tillman, B.W., Krasnykh, V., and Curiel, D.T. (2004). Adenovirus-mediated gene delivery to dendritic cells. Methods Mol. Biol. 246, 139-154.
65. Wade-Martins, R., Frampton, J., and James, M.R. (1999). Longterm stability of large insert genomic DNA episomal shuttle vectors in human cells. Nucleic Acids Res. 27, 1674-1682.
66. Wade-Martins, R., Smith, E.R., Tyminski, E., Chiocca, E.A., and Saeki, Y. (2001). An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat. Biotechnol. 19, 1067-1070.
67. Wade-Martins, R., Saeki, Y., and Chiocca, E.A. (2003). Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells. Mol. Ther. 7, 604-612.
68. Willis, R.A., Bowers, W.J., Turner, M.J., Fisher, T.L., Abdul-Alim, C.S., Howard, D.F., Federoff, H.J., Lord, E.M., and Frelinger, J.G. (2001). Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice. Hum. Gene Ther. 12, 1867-1879.
69. Yamanaka, R., Zullo, S.A., Tanaka, R., Blaese, M., and Xanthopoulos, K.G. (2001). Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki Forest virus-mediated complementary DNA. J. Neurosurg. 94, 474-481.
70. Yao, Y., Li, P., Singh, P., Thiele, A.T., Wilkes, D.S., Renuka-radhya, G.J., Brutkiewicz, R.R., Travers, J.B., Luker, G.D., Hong, S.C., Blum, J.S., and Chang, C.H. (2007). Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. Cell. Immunol. 246, 92-102.
71. Zager, J.S., Delman, K.A., Malhotra, S., Ebright, M.I., Bennett, J.J., Kates, T., Halterman, M., Federoff, H., and Fong, Y. (2001). Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer. Mol. Med. 7, 561-568.
72. Zhang, W., Yang, H., Wang, Z., and Jim, X. (2002). TNF-α gene-modified dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity in mice. Chin. Med. J. (Engl) 115, 1767-1771.
73. Ziegler-Heitbrock, H.W. (2000). Definition of human blood monocytes. J. Leukoc. Biol. 67, 603-606.